Zynex, Inc. (ZYXI)

NASDAQ: ZYXI · IEX Real-Time Price · USD
9.02
+0.36 (4.16%)
Sep 27, 2022 4:00 PM EDT - Market closed
4.16%
Market Cap 346.43M
Revenue (ttm) 142.99M
Net Income (ttm) 19.72M
Shares Out 38.41M
EPS (ttm) 0.49
PE Ratio 18.41
Forward PE 15.82
Dividend $0.10 (1.11%)
Ex-Dividend Date n/a
Volume 152,868
Open 8.72
Previous Close 8.66
Day's Range 8.72 - 9.22
52-Week Range 4.97 - 14.24
Beta 0.81
Analysts Buy
Price Target 16.96 (+88.0%)
Earnings Date Oct 31, 2022

About ZYXI

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InW... [Read more...]

Industry Health Care Equipment & Supplies
Founded 1996
Employees 774
Stock Exchange NASDAQ
Ticker Symbol ZYXI
Full Company Profile

Financial Performance

In 2021, Zynex's revenue was $130.30 million, an increase of 62.63% compared to the previous year's $80.12 million. Earnings were $17.10 million, an increase of 88.48%.

Financial Statements

Analyst Forecast

According to 10 analysts, the average rating for ZYXI stock is "Buy." The 12-month stock price forecast is 16.96, which is an increase of 88.03% from the latest price.

Price Target
$16.96
(88.03% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Zynex Monitoring Solutions Announces First Enrollment in a Blood Loss Detection Clinical Trial for its CM-1600 Monito...

ENGLEWOOD, Colo. , Sept. 21, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain m...

6 days ago - PRNewsWire

7 Hot Small-Cap Stocks to Buy in September

In general, finding small-cap stocks to buy can be somewhat fraught. These are stocks with market capitalizations between roughly $300 million and $2 billion.

Other symbols: APMTSRIVTVTYTRA
3 weeks ago - InvestorPlace

Zynex Medical to Participate in H.C. Wainwright Annual Global Investment Conference

ENGLEWOOD, Colo. , Sept. 1, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ma...

3 weeks ago - PRNewsWire

Zynex Medical to Participate in Inaugural Gilmartin Group Emerging Growth Company Showcase

ENGLEWOOD, Colo. , Aug. 23, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ma...

1 month ago - PRNewsWire

Zynex Announces First Enrollments in Apheresis Donation Clinical Trial with Second Generation Fluid Monitoring System

ENGLEWOOD, Colo. , Aug. 15, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ma...

1 month ago - PRNewsWire

Zynex Recognized in Top 100 Healthcare Technology Companies of 2022

ENGLEWOOD, Colo. , Aug. 8, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain mana...

1 month ago - PRNewsWire

Zynex Ranked in Top 50 Public Companies in Colorado

ENGLEWOOD, Colo. , Aug. 3, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain man...

1 month ago - PRNewsWire

Zynex Inc. (ZYXI) Tops Q2 Earnings and Revenue Estimates

Zynex Inc. (ZYXI) delivered earnings and revenue surprises of 14.29% and 0.92%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Zynex Announces 2022 Second Quarter Earnings

ENGLEWOOD, Colo., July 28, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain mana...

1 month ago - PRNewsWire

Zynex, Inc. to Announce Second Quarter 2022 Financial Results

ENGLEWOOD, Colo. , July 20, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ma...

2 months ago - PRNewsWire

Zynex Reports Preliminary Second Quarter 2022 Results and Reiterates Full Year Revenue and EBITDA Guidance

ENGLEWOOD, Colo.  , July 11, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain m...

2 months ago - PRNewsWire

Zynex Announces Change of Auditor

ENGLEWOOD, Colo. , June 13, 2022 /PRNewswire/ -- Zynex, Inc. ("Zynex or the "Company) (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive me...

3 months ago - PRNewsWire

Zynex Announces Additional Share Buyback Program

ENGLEWOOD, Colo. , June 9, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain man...

3 months ago - PRNewsWire

Zynex Medical to Participate in Upcoming Investor Conferences

ENGLEWOOD, Colo. , May 10, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain man...

4 months ago - PRNewsWire

Zynex Ranks 250 in Financial Times List of "The Americas' Fastest Growing Companies 2022"

ENGLEWOOD, Colo. , May 3, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain mana...

4 months ago - PRNewsWire

Zynex Inc. (ZYXI) Q1 Earnings Miss Estimates

Zynex Inc. (ZYXI) delivered earnings and revenue surprises of -40% and 0.66%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

Zynex Announces 2022 First Quarter Earnings

ENGLEWOOD, Colo., April 28, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain man...

4 months ago - PRNewsWire

Zynex, Inc. to Announce First Quarter 2022 Financial Results

ENGLEWOOD, Colo. , April 18, 2022 /PRNewswire/ -- April 18, 2022 – Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical d...

5 months ago - PRNewsWire

Zynex Announces Share Buyback Program

ENGLEWOOD, Colo. , April 11, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ma...

5 months ago - PRNewsWire

Zynex Reports Preliminary First Quarter 2022 Results and Provides Business Update

ENGLEWOOD, Colo. , April 8, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ma...

5 months ago - PRNewsWire

Zynex Recognized as Fourth Largest Biotechnology/Bioscience Company in Colorado

ENGLEWOOD, Colo., March 23, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain man...

6 months ago - PRNewsWire

Zynex Inc. (ZYXI) Q4 Earnings Surpass Estimates

Zynex Inc. (ZYXI) delivered earnings and revenue surprises of 21.05% and 1.69%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

7 months ago - Zacks Investment Research

Zynex Announces 2021 Fourth Quarter and Full Year Earnings

ENGLEWOOD, Colo., Feb. 24, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain mana...

7 months ago - PRNewsWire

Zynex Anticipates No Material Change in Revenue from Switch in United Health Care Prescription Coverage

ENGLEWOOD, Colo., Feb. 18, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain man...

7 months ago - PRNewsWire

Zynex, Inc. to Announce Fourth Quarter 2021 Financial Results

ENGLEWOOD, Colo., Feb. 8, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain mana...

7 months ago - PRNewsWire